US6673109B2
Expired / Lapsed
US
⏱️ 0.0 years remaining
Replacement atrioventricular heart valve
Assignee: Medtronic 3F Therapeutics Inc
•
Filing: 2001-08-07
•
Granted: 2004-01-06
•
Expires: 2021-08-07
Abstract
Abstract A method is disclosed for using tubular material to replace a semilunar heart valve (i.e., an aortic or pulmonary valve). To create such a replacement valve, the native valve cusps are removed from inside an aorta or pulmonary artery, and the inlet end of a tubular segment is sutured to the valve annulus. The outlet (distal) end of the tube is either “tacked” at three points distally, or sutured longitudinally along three lines; either method will allow the flaps of tissue between the suture lines to function as movable cusps. This approach generates flow patterns that reduce turbulence and closely duplicate the flow patterns of native semilunar valves. An article of manufacture is also disclosed, comprising a sterile biocompatible synthetic material which has been manufactured in tubular form, by methods such as extrusion or coating a cylindrical molding device, to avoid a need for a suture line or other seam to convert a flat sheet of material into a tubular shape. The synthetic tube is packaged within a sealed watertight enclosure that maintains sterility of the tube.
Inventors
- 👤 James L. Cox
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-22 21:59
CPC Classifications
A; A61; A61L; A61L27/00; A61L27/36; A61L27/38; A61L27/3839; A61L27/3843; A61F; A61F2/00; A61F2/0095; A61F2/02; A61F2/24; A61F2/2412; A61L27/3604; A61L27/3629; A61L27/3641; A61L27/3645; A61L27/50; A61L27/507; G; G06; G06Q; G06Q40/00; G06Q40/04; A61L2430/00; A61L2430/20; Y; Y10; Y10S; Y10S623/00; Y10S623/90; Y10S623/901
Claims Analysis
Total Claims: 11
Claim 1
Independent Claim
205 words
A replacement atrioventricular heart valve suitable for placement in a heart of a patient, comprising: an elongate, tubular starting material, comprising: a thin and flexible wall portion having diametrically opposing sides; an inlet end and an outlet end, the inlet end sized and adapted to be circumferentially secured substantially flush with a valve annulus formed by removing a native atrioventricular heart valve, the tubular starting material sized so that when the inlet end is secured in the annulus, the outlet end lies adjacent at least some papillary muscles or chordae tendinea that have been detached from their associated native atrioventricular heart valve; at least two securement portions adjacent the outlet end and spaced from each other, the securement portions adapted to be attached to papillary muscles or chordae tendinea; and unconstrained regions between the securement portions, the unconstrained regions adapted to flex inwardly into and out of engagement with each other so that when the regions are engaged, a line of commissure is created that resembles native atrioventricular valve leaflet commissure wherein the tubular starting material of the replacement atrioventricular heart valve is derived from one or more of the following materials: synthetic material, pericardial sac, fascia lata, intestinal tissue segment, or animal tissue culture.
Claim 2
Dependent Claim
205 words
A replacement atrioventricular heart valve suitable for placement in a heart of a patient, comprising: an elongate, tubular starting material, comprising: a thin and flexible wall portion having diametrically opposing sides; an inlet end and an outlet end, the inlet end sized and adapted to be circumferentially secured substantially flush with a valve annulus formed by removing a native atrioventricular heart valve, the tubular starting material sized so that when the inlet end is secured in the annulus, the outlet end lies adjacent at least some papillary muscles or chordae tendinea that have been detached from their associated native atrioventricular heart valve; at least two securement portions adjacent the outlet end and spaced from each other, the securement portions adapted to be attached to papillary muscles or chordae tendinea; and unconstrained regions between the securement portions, the unconstrained regions adapted to flex inwardly into and out of engagement with each other so that when the regions are engaged, a line of commissure is created that resembles native atrioventricular valve leaflet commissure wherein the tubular starting material of the replacement atrioventricular heart valve is derived from one or more of the following materials: synthetic material, pericardial sac, fascia lata, intestinal tissue segment, or animal tissue culture.
Claim 3
Dependent Claim
23 words
A heart valve as in claim 1 , wherein the tubular starting material is characterized by an absence of an artificially-created longitudinal seam.
Claim 4
Dependent Claim
20 words
A heart valve as in claim 2 , wherein the tubular starting material consists of a substantially tubular synthetic material.
Claim 5
Dependent Claim
18 words
A heart valve as in claim 1 , wherein the tubular starting material consists of essentially synthetic material.
Claim 6
Dependent Claim
18 words
A heart valve as in claim 1 , wherein the tubular starting material consists of essentially biological material.
Claim 7
Dependent Claim
14 words
A heart valve as in claim 1 , in combination with an annuloplasty ring.
Claim 8
Dependent Claim
12 words
A heart valve as in claim 1 , additionally comprising reinforcing strips.
Claim 9
Dependent Claim
16 words
A heart valve as in claim 7 , wherein the reinforcing strips comprise essentially synthetic material.
Claim 10
Dependent Claim
24 words
A heart valve as in claim 1 , in combination with a sealed container, wherein the heart valve is enclosed within the sealed container.
Claim 11
Dependent Claim
52 words
A heart valve as in claim 1 , wherein the outlet end lies adjacent at least some papillary muscles that have been detached from their associated chordae tendinea, and the securement portions are positioned so as to engage the papillary muscles at substantially the same locations vacated by the removed chordae tendinea.
References Cited (Backward Citations)
US3587115A
Cited
US3608097A
Cited
US3671979A
Cited
US3988782A
Cited
US3898701A
Cited
US3966401A
Cited
US4011947A
Cited
US4065816A
Cited
US4108161A
Cited
US4106129A
Cited
US4056854A
Cited
US4297749A
Cited
US4306318A
Cited
US4261342A
Cited
US4222126A
Cited
US4211325A
Cited
US4343048A
Cited
EP0051451A2
Cited
US4470157A
Cited
US4501030A
Cited
EP0103546B1
Cited
US4601718A
Cited
US4801299A
Cited
US4545783A
Cited
US4612011A
Cited
US4626255A
Cited
US4629459A
Cited
US4512471A
Cited
US4697703A
Cited
US4790844A
Cited
EP0276975A1
Cited
US4750619A
Cited
US5031762A
Cited
US4838288A
Cited
US4960424A
Cited
US4863016A
Cited
US5037434A
Cited
US5411552A
Cited
US5840081A
Cited
US5415667A
Cited
US5163955A
Cited
US5344442A
Cited
US5500015A
Cited
US5713953A
Cited
US5370685A
Cited
US5332402A
Cited
US5733331A
Cited
EP0581233A1
Cited
US5910169A
Cited
US5385229A
Cited
US5607477A
Cited
US5460962A
Cited
US5824065A
Cited
US5824067A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 2007-01-05 | 2007-07-07 | 2008-01-06 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2011-01-05 | 2011-07-07 | 2012-01-06 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2015-01-05 | 2015-07-07 | 2016-01-06 | $7700.00 | Window Closed / Lapsed |